ProShares Ultra Nasdaq Biotechnology (BIB) closed at $112.85 on October 22, 2026, down 1.6% from the previous close, on volume of 7,829 shares (30-day average 7,471).
Data as of October 22, 2026.
22-Oct-2026
No press releases found.
No science background? AI does the lab work
Seeking Alpha News (Tue, 20-Oct 11:11 AM ET)
ProShares Ultra Nasdaq Biotechnology seeks daily investment results before fees and expenses that correspond to twice (200%) the daily performance of the NASDAQ Biotechnology Index.
ProShares Ultra Nasdaq Biotechnology trades on the NASDAQ stock market under the symbol BIB.
As of October 22, 2026, BIB stock price declined to $112.85 with 7,829 million shares trading.
BIB has a market cap of $94.79 million. This is considered a Micro Cap stock.
In the last 3 years, BIB traded as high as $126.40 and as low as $33.78.
BIB has outperformed the market in the last year with a price return of +71.0% while the SPY ETF gained +15.5%. BIB has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +15.9% and +7.5%, respectively, while the SPY returned +2.5% and -1.3%, respectively.
BIB support price is $110.71 and resistance is $118.70 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BIB shares will trade within this expected range on the day.
